1. Home
  2. SLN vs WILC Comparison

SLN vs WILC Comparison

Compare SLN & WILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLN
  • WILC
  • Stock Information
  • Founded
  • SLN 1994
  • WILC 1994
  • Country
  • SLN United Kingdom
  • WILC Israel
  • Employees
  • SLN N/A
  • WILC N/A
  • Industry
  • SLN Biotechnology: Pharmaceutical Preparations
  • WILC Food Distributors
  • Sector
  • SLN Health Care
  • WILC Consumer Discretionary
  • Exchange
  • SLN Nasdaq
  • WILC Nasdaq
  • Market Cap
  • SLN 273.9M
  • WILC 271.3M
  • IPO Year
  • SLN N/A
  • WILC 1997
  • Fundamental
  • Price
  • SLN $6.11
  • WILC $19.57
  • Analyst Decision
  • SLN Buy
  • WILC
  • Analyst Count
  • SLN 5
  • WILC 0
  • Target Price
  • SLN $32.60
  • WILC N/A
  • AVG Volume (30 Days)
  • SLN 105.4K
  • WILC 31.6K
  • Earning Date
  • SLN 08-14-2025
  • WILC 08-12-2025
  • Dividend Yield
  • SLN N/A
  • WILC 4.92%
  • EPS Growth
  • SLN N/A
  • WILC 80.33
  • EPS
  • SLN N/A
  • WILC 1.37
  • Revenue
  • SLN $27,701,000.00
  • WILC $157,003,357.00
  • Revenue This Year
  • SLN N/A
  • WILC N/A
  • Revenue Next Year
  • SLN N/A
  • WILC N/A
  • P/E Ratio
  • SLN N/A
  • WILC $14.51
  • Revenue Growth
  • SLN N/A
  • WILC 10.73
  • 52 Week Low
  • SLN $1.97
  • WILC $9.04
  • 52 Week High
  • SLN $22.47
  • WILC $20.32
  • Technical
  • Relative Strength Index (RSI)
  • SLN 55.70
  • WILC 69.34
  • Support Level
  • SLN $6.10
  • WILC $19.55
  • Resistance Level
  • SLN $6.67
  • WILC $20.26
  • Average True Range (ATR)
  • SLN 0.39
  • WILC 0.50
  • MACD
  • SLN -0.02
  • WILC 0.02
  • Stochastic Oscillator
  • SLN 59.70
  • WILC 80.76

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

About WILC G. Willi-Food International Ltd.

G. Willi-Food International Ltd is a company engaged in high-quality, great-tasting kosher food products. The Company is engaged, directly and through subsidiaries, with one segment Import-export, marketing, and distribution of food products. The principal product line includes Canned Vegetables and Pickles, Canned Fish, Canned Fruit, Edible Oils, Dairy and Dairy Substitute Products, Dried Fruit, Nuts and Beans, and Other Products. Its brands include Willi-Food, Euro European Dairies, Donna Rozza, Manchow, Gold Frost, Tifeeret, The Chef Dish, Art Coffe, Mr. Chang, Muchi, Euro Butter, Euro Spread, Euro Cheese, Euro Cream, Euro Dessert, Euro Veg, Ha-Bulgaria, Gelato, and Emma.

Share on Social Networks: